Filing Flows › Atara Biotherapeutics (ATRA) › How it makes money
How Atara Biotherapeutics (ATRA) makes money
Atara Biotherapeutics (ATRA) made $630K of revenue in the second quarter 2026 (Q2 2026), -96% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $630K | 100.0% |
| Income tax | $1K | 0.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $630K | -96% |
| Q1 2026 | $516K | -100% |
| Q4 2025 | $1.6M | -95% |
| Q3 2025 | $3.5M | -91% |
| Q2 2025 | $17.6M | -39% |
| Q1 2025 | $98.1M | +259% |
| Q4 2024 | $32.8M | +670% |
From Atara Biotherapeutics' 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does Atara Biotherapeutics make money?
Atara Biotherapeutics (ATRA) made $630K of revenue in the second quarter 2026 (Q2 2026), -96% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.